Cargando…
Post-operative thromboprophylaxis: new oral thrombin and factor X inhibitors and their place in clinical practice
Thromboprophylaxis can reduce the incidence of postoperative thromboembolic events by two-thirds. Traditionally, unfractionated heparin, low-molecular-weight heparins, vitamin K antagonists, and mechanical methods have been used. Recently, thrombin and factor Xa (FXa) antagonists have been introduce...
Autores principales: | Filipovic, Miodrag, Schnider, Thomas |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medicine Reports Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950043/ https://www.ncbi.nlm.nih.gov/pubmed/20948848 http://dx.doi.org/10.3410/M2-37 |
Ejemplares similares
-
The Drug Titration Paradox: Correlation of More Drug With Less Effect in Clinical Data
por: Schnider, Thomas W., et al.
Publicado: (2021) -
COVID-19 Is Associated with Endothelial Dysfunction and Enhanced Plasma Thrombin Generation Despite Pharmacological Thromboprophylaxis
por: Kelliher, Sarah, et al.
Publicado: (2021) -
Efficacy and Safety of Thromboprophylaxis Post-Orthopedic Surgery
por: Alsheikh, Khalid, et al.
Publicado: (2021) -
New Oral Anticoagulants for Thromboprophylaxis after Elective Total Hip and Knee Arthroplasty
por: Friedman, Richard J.
Publicado: (2010) -
Development of Orally Active Thrombin Inhibitors for the Treatment of Thrombotic Disorder Diseases
por: He, Li-Wei, et al.
Publicado: (2015)